Literature DB >> 19058847

Uric acid inhibits placental system A amino acid uptake.

S A Bainbridge1, F von Versen-Höynck, J M Roberts.   

Abstract

Hyperuricemia, a common clinical characteristic of preeclamptic pregnancies, has historically been considered a marker of reduced renal function in preeclamptic women. More recently it has been suggested that uric acid may directly contribute to pathological cell signaling events involved in disease progression as well as maternal and fetal pregnancy outcomes including fetal growth restriction. We hypothesize that the increased frequency of restricted fetal growth seen in relation to increasing uric acid concentrations in preeclamptic women is in part the result of uric acid-induced reductions in amino acid transport across the placenta. The objective of the current study was to examine the effects of uric acid on human placental System A amino acid transport using a primary placental villous explant model. Further, we examined the necessity of uric acid uptake and the role of redox signaling as a potential mechanism through which uric acid may attenuate System A activity. Placental uptake of a radiolabeled amino acid analogue, specific to the System A transporter, was reduced in a concentration-dependent fashion with increasing uric acid (0-7 mg/dL), corresponding to uric acid concentrations measured in healthy pregnant and preeclamptic women in the third trimester. Uric acid-induced reduction in System A activity was partially reversed by NADPH oxidase inhibition and completely eliminated by antioxidant treatment. This study demonstrates inhibition of placental System A amino acid transport with uric acid treatment, as a result of uric acid-induced stimulation of intracellular redox signaling cascades. These findings may be relevant to the increased frequency of fetal growth restriction observed in hyperuricemic preeclampsia. Additionally the results of this study, indicating a detrimental effect of hyperuricemia on amino acid transport in the placenta, at concentrations present in women with preeclampsia, also suggest a role for uric acid in the pathophysiology of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058847      PMCID: PMC2677697          DOI: 10.1016/j.placenta.2008.10.015

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  42 in total

1.  Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta.

Authors:  S H Cha; T Sekine; H Kusuhara; E Yu; J Y Kim; D K Kim; Y Sugiyama; Y Kanai; H Endou
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 2.  Intrauterine growth restriction.

Authors:  Robert Resnik
Journal:  Obstet Gynecol       Date:  2002-03       Impact factor: 7.661

3.  Physiological importance of system A-mediated amino acid transport to rat fetal development.

Authors:  Stuart Cramer; Mark Beveridge; Michael Kilberg; Donald Novak
Journal:  Am J Physiol Cell Physiol       Date:  2002-01       Impact factor: 4.249

Review 4.  Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Authors:  Richard J Johnson; Duk-Hee Kang; Daniel Feig; Salah Kivlighn; John Kanellis; Susumu Watanabe; Katherine R Tuttle; Bernardo Rodriguez-Iturbe; Jaime Herrera-Acosta; Marilda Mazzali
Journal:  Hypertension       Date:  2003-04-21       Impact factor: 10.190

5.  Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery.

Authors:  Robert W Powers; Lisa M Bodnar; Roberta B Ness; Katheryn M Cooper; Marcia J Gallaher; Michael P Frank; Ashi R Daftary; James M Roberts
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

Review 6.  Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link.

Authors:  Duk-Hee Kang; Jennifer Finch; Takahiko Nakagawa; S Ananth Karumanchi; John Kanellis; Joey Granger; Richard J Johnson
Journal:  J Hypertens       Date:  2004-02       Impact factor: 4.844

7.  Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

Authors:  John Kanellis; Susumu Watanabe; Jin H Li; Duk Hee Kang; Ping Li; Takahiko Nakagawa; Ann Wamsley; David Sheikh-Hamad; Hui Y Lan; Lili Feng; Richard J Johnson
Journal:  Hypertension       Date:  2003-05-12       Impact factor: 10.190

8.  Inhibition of Na+, K+-ATPase activity in rat striatum by the metabolites accumulated in Lesch-Nyhan disease.

Authors:  Caren S Bavaresco; Alexandra I Zugno; Bárbara Tagliari; Clóvis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Int J Dev Neurosci       Date:  2004-02       Impact factor: 2.457

Review 9.  Recent Insights into the pathogenesis of pre-eclampsia.

Authors:  J M Roberts; K Y Lain
Journal:  Placenta       Date:  2002-05       Impact factor: 3.481

10.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Authors:  James M Roberts; Gail D Pearson; Jeffrey A Cutler; Marshall D Lindheimer
Journal:  Hypertens Pregnancy       Date:  2003       Impact factor: 2.108

View more
  16 in total

1.  Uric Acid Crystals Induce Placental Inflammation and Alter Trophoblast Function via an IL-1-Dependent Pathway: Implications for Fetal Growth Restriction.

Authors:  Marie-Eve Brien; Cyntia Duval; Julia Palacios; Ines Boufaied; Andrée-Anne Hudon-Thibeault; Mathieu Nadeau-Vallée; Cathy Vaillancourt; Colin P Sibley; Vikki M Abrahams; Rebecca L Jones; Sylvie Girard
Journal:  J Immunol       Date:  2016-11-30       Impact factor: 5.422

2.  First trimester uric acid and adverse pregnancy outcomes.

Authors:  S Katherine Laughon; Janet Catov; Robert W Powers; James M Roberts; Robin E Gandley
Journal:  Am J Hypertens       Date:  2011-01-20       Impact factor: 2.689

3.  Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.

Authors:  Che-Jung Chang; Dana Boyd Barr; P Barry Ryan; Parinya Panuwet; Melissa M Smarr; Ken Liu; Kurunthachalam Kannan; Volha Yakimavets; Youran Tan; ViLinh Ly; Carmen J Marsit; Dean P Jones; Elizabeth J Corwin; Anne L Dunlop; Donghai Liang
Journal:  Environ Int       Date:  2021-11-01       Impact factor: 9.621

4.  Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers.

Authors:  Shannon A Bainbridge; James M Roberts; Frauke von Versen-Höynck; Jessa Koch; Lia Edmunds; Carl A Hubel
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-17       Impact factor: 4.249

5.  Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women.

Authors:  S Katherine Laughon; Janet Catov; James M Roberts
Journal:  Am J Obstet Gynecol       Date:  2009-09-02       Impact factor: 8.661

6.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

7.  Maternal hyperuricemia in normotensive singleton pregnancy, a prenatal finding with continuous perinatal and postnatal effects, a prospective cohort study.

Authors:  Elaheh Amini; Mahdi Sheikh; Sedigheh Hantoushzadeh; Mamak Shariat; Alireza Abdollahi; Maryam Kashanian
Journal:  BMC Pregnancy Childbirth       Date:  2014-03-18       Impact factor: 3.007

8.  Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010.

Authors:  Lyndsey A Darrow; Cheryl R Stein; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2013-07-09       Impact factor: 9.031

9.  Uric acid: A hypothetical cause of preeclampsia-eclampsia.

Authors:  Emmanuel Stephen Mador; Ishaya Chuwang Pam; Christian Ogoegbunem Isichei
Journal:  Niger Med J       Date:  2013-09

10.  Study of serum uric acid and creatinine in hypertensive disorders of pregnancy.

Authors:  Sapna Vyakaranam; Aparna Varma Bhongir; Dakshayani Patlolla; Rekha Chintapally
Journal:  Int J Med Sci Public Health       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.